Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data

被引：0
|
作者：
Heran Deng
Liying Wang
Na Wang
Kejin Zhang
Yanxia Zhao
Pengfei Qiu
Xiaowei Qi
Danhua Zhang
Fei Xu
Jieqiong Liu
机构：
[1] Sun Yat-Sen Memorial Hospital,Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Center
[2] Sun Yat-Sen University,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[3] Sun Yat-Sen University Cancer Center,undefined
[4] Sun Yat-Sen University,undefined
[5] Xiangya Hospital of Central South University,undefined
[6] Center South University,undefined
[7] Union Hospital Tongji Medical College Huazhong University of Science and Technology,undefined
[8] Huazhong University of Science and Technology,undefined
[9] Shandong Tumor Hospital,undefined
[10] Shandong university,undefined
[11] The Southwest Hospital of AMU,undefined
[12] Army Medical University,undefined
[13] The Second Xiangya Hospital of Central South University,undefined
[14] Center South University,undefined
来源：
BMC Cancer | / 23卷
关键词：
Tripe-negative breast cancer; Neoadjuvant immunotherapy; Anti-PD-1/L1 antibody; Real-world study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Breast cancer patients' quality of life: Real-world data
    Kosmidis, T.
    Athanasakou, B.
    Kosmidis, P. A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [32] Real-world outcomes of neoadjuvant chemotherapy for breast cancer: Reflections from a community cancer center.
    Bhardwaj, Prarthna V.
    Kaufman, Seth
    Mason, Holly
    Visintainer, Paul
    Makari-Judson, Grace
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18690 - E18690
  • [33] A real-world clinicopathological model for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer
    Fang, Shan
    Xia, Wenjie
    Zhang, Haibo
    Ni, Chao
    Wu, Jun
    Mo, Qiuping
    Jiang, Mengjie
    Guan, Dandan
    Yuan, Hongjun
    Chen, Wuzhen
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] Real-World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy
    Cabrera-Galeana, Paula
    Soto-Perez-de-Celis, Enrique
    Reynoso-Noveron, Nancy
    Villarreal-Garza, Cynthia
    Lara-Medina, Fernando
    Alvarado-Miranda, Alberto
    Rodrigo Espinosa-Fernandez, Jose
    Esparza-Arias, Nereida
    Mohar, Alejandro
    Enrique Bargallo-Rocha, Juan
    ONCOLOGIST, 2020, 25 (12): : 1023 - 1031
  • [35] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    da Silva, Leonardo Roberto
    de Andrade, Camila Annicchino
    Brenelli, Fabricio
    Ramalho, Susana
    Reinert, Tomas
    de Souza, Alessandra Borba Anton
    da Silva, Ana Elisa Ribeiro
    de Paula Leite Kraft, Maria Beatriz
    de Vasconcelos, Vivian Castro Antunes
    Frasson, Antonio Luiz
    Torresan, Renato Zochio
    Cabello, Cesar
    Ellis, Matthew J.
    Zeferino, Luiz Carlos
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 753 - 760
  • [36] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    Leonardo Roberto da Silva
    Camila Annicchino de Andrade
    Fabrício Brenelli
    Susana Ramalho
    Tomás Reinert
    Alessandra Borba Anton de Souza
    Ana Elisa Ribeiro da Silva
    Maria Beatriz de Paula Leite Kraft
    Vivian Castro Antunes de Vasconcelos
    Antônio Luiz Frasson
    Renato Zochio Torresan
    Cesar Cabello
    Matthew J. Ellis
    Luiz Carlos Zeferino
    Breast Cancer Research and Treatment, 2021, 186 : 753 - 760
  • [37] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhao, Weihong
    Zhang, Zheng
    Zhang, Yadi
    Chen, Yimeng
    Zhu, Yimin
    Liu, Chuanling
    Shao, Jiakang
    Zhang, Li
    Liu, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhang, Zheng
    Zhang, Yadi
    Liu, Chuanling
    Shao, Jiakang
    Chen, Yimeng
    Zhu, Yimin
    Zhang, Li
    Qin, Boyu
    Kong, Ziqing
    Wang, Xixi
    Wang, Yutong
    Huang, Deqin
    Liu, Liqun
    Zhou, Yuxin
    Tao, Ran
    Yang, Zengjie
    Liu, Mei
    Zhao, Weihong
    CANCER INNOVATION, 2023, 2 (03): : 172 - 180
  • [39] The efficacy and safety of trastuzumab and pertuzumab in combination with different chemotherapy regimens for neoadjuvant treatment of HER2-posotive breast cancer: a multicenter real-world study in China
    Qi, Xiaowei
    Hu, Hong
    Chen, Wenlin
    Yan, Xu
    Shu, Liu
    Fang, Yanman
    Li, Taolang
    Jia, Ming
    Zhou, Sihai
    Fan, Chai
    Liang, Yueyang
    Fan, Yuanming
    Zhang, Yi
    Tang, Peng
    Jun, Jiang
    Nie, Jianyun
    Chen, Li
    Wang, Shushu
    CANCER RESEARCH, 2023, 83 (05)
  • [40] Real-world data (RWD) from patients with triple-negative breast cancer (TNBC) receiving pembrolizumab with neoadjuvant chemotherapy (NACT plus P) versus NACT alone
    Mckeon, J.
    Daniels, E.
    Gibbs, L.
    Comins, C.
    Jenkins, J.
    Strawson-Smith, T.
    Mohan, V.
    Allah, M. H.
    Braybrooke, J.
    Robinson, T.
    CLINICAL ONCOLOGY, 2025, 38
12345